SCHEMBL23309533

SCHEMBL23309533

Cc1cc(NC(=O)c2cc(F)nc(F)c2F)ccc1F

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ NPC1 O15118 7/20 0.42
▸ RAB9A P51151 7/20 0.42
▸ MAPT P10636 2/20 0.42
▸ LMNA P02545 2/20 0.42
▸ THRB P10828 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ KDR P35968 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ POLB P06746 1/20 0.41
▸ PKM P14618 1/20 0.41
▸ GRM4 Q14833 1/20 0.41
▸ CTDSP1 Q9GZU7 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ BLM P54132 1/20 0.40
▸ GRM5 P41594 1/20 0.40
▸ KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309483 0.90 CYP1A2 (0.52) ALDH1A1HSD17B10NPC1RAB9AMAPT
SCHEMBL23309702 0.89 ALDH1A1 (0.55) ALDH1A1HSD17B10NPC1RAB9AMAPT
SCHEMBL23309703 0.87 RAB9A (0.51) ALDH1A1NPC1RAB9ALMNASMN1; SMN2
SCHEMBL23309730 0.85 KMT2A (0.47) ALDH1A1NPC1RAB9AMAPTLMNA
SCHEMBL23309621 0.85 RAB9A (0.50) ALDH1A1HSD17B10NPC1RAB9AMAPT
SCHEMBL23309492 0.84 RAB9A (0.45) ALDH1A1HSD17B10NPC1RAB9AMAPT
SCHEMBL23309566 0.84 ALDH1A1 (0.41) ALDH1A1HSD17B10NPC1RAB9ACYP1A2
SCHEMBL23309539 0.84 NPC1 (0.52) ALDH1A1HSD17B10NPC1RAB9AMAPT
SCHEMBL23309495 0.84 FADS1 (0.56) ALDH1A1NPC1RAB9AMAPTLMNA
SCHEMBL23309708 0.82 RAB9A (0.52) ALDH1A1NPC1RAB9ALMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL ALDH1A1 2033/4885HSD17B10 1857/4885NPC1 412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback